What’s listed.
Ten ingredients. One three-capsule pack.
The amounts below reflect the formula supplied by the maker and the owner’s latest clarification.
| Ingredient | Listed amount |
|---|---|
| Ginger | 1,000 mg |
| Turmeric | 600 mg |
| Black pepper extract | 6 mg |
| Clove | 200 mg |
| Alpha-GPC | 350 mg |
| L-Theanine | 350 mg |
| Magnesium glycinate | 300 mg |
| Vitamin B3 | 1 mg |
| Vitamin B6 | 10 mg |
| Vitamin B12 | 10 mg |
Magnesium is listed here as 300 mg magnesium glycinate, not as an elemental-magnesium amount. Vitamin B12 is 10 mg (10,000 mcg). This is a supplied formulation summary, not an independently verified Supplement Facts panel or laboratory assay. Extract standardizations and vitamin forms are not specified here.
Gut and mind,
considered together.
The maker’s original brief pairs digestive comfort with mental steadiness and identifies psychedelic-assisted therapy clinics as the intended audience. A fuller scientific explanation was not supplied; the interpretation below is a research hypothesis.
Could digestive comfort, a steadier response to stress, and changes in inflammatory signaling complement one another?
Ginger anchors the digestive-comfort question. L-Theanine anchors the stress-response question. Magnesium and B vitamins contribute a nutritional rationale, while Alpha-GPC introduces a separate line of research on cognition. Turmeric, black pepper extract, and clove connect the formula to research on plant compounds, absorption, and inflammatory pathways.
The proposed relationship is complementary. Whether this particular combination produces a useful effect, whether its ingredients improve one another’s effects, and whether it changes a psychedelic experience remain questions to investigate.
Promising leads.
Different levels
of evidence.
Research ranges from controlled human studies to cell experiments and early reports. Open each topic for the finding, the formulation comparison, and the original source. This is a focused review, not a systematic review.
Ginger and digestive comfort
Ginger has human evidence for some causes of nausea, especially nausea and vomiting during pregnancy. Findings differ across conditions; evidence for one cause does not establish a benefit for another.
For this formula: 1,000 mg of ginger supplies a concrete amount for comparison, but preparation and active-compound content still matter. The reviewed evidence does not establish that Sitter prevents psychedelic-related nausea. Ginger itself can cause heartburn or abdominal discomfort.
Ginger, turmeric, and black pepper
A 2022 study measured synergy between characterized ginger and turmeric extracts on inflammatory signals in cell models. The most favorable tested ratio was 5:2. Sitter’s listed ginger-to-turmeric ratio is 5:3; the ingredient preparations are also not established as equivalent.
Piperine increased curcumin exposure in a human pharmacokinetic study. Greater absorption does not by itself establish better clinical outcomes. Black pepper extract is not necessarily pure piperine, and turmeric is not necessarily a standardized curcumin extract.
A 2025 migraine trial protocol proposes testing curcumin, gingerol, and piperine together, including inflammatory and mental-health measures. A protocol describes a planned study, not demonstrated results. These findings support research questions about complementary activity; they do not prove general inflammation relief from Sitter.
Clove compounds and psychedelic research
Researchers have studied psilocybin alongside eugenol, a clove constituent, and other plant compounds. A 2023 experiment in laboratory-grown human intestinal tissue reported reductions in inflammatory markers with psilocybin and eugenol, but minimal synergy in that model. Human tissue in a laboratory is not a human clinical trial.
Related experiments examined neuroinflammation and liver inflammation in mice. Much of this work comes from the same research program, with GoodCap Pharmaceuticals involvement; it does not represent independent human replication.
For this formula: this is a direct experimental connection between a clove compound and psychedelic research. However, 200 mg of clove is not 200 mg of eugenol. The studies do not establish a safe combination, an effective oral amount, or improved psychedelic experiences from Sitter.
L-Theanine and the response to stress
A small, supplier-funded crossover trial found changes in brain-wave activity and cortisol during a laboratory stress challenge after L-Theanine. This supports further study of stress responses.
The broader picture is mixed. A trial in generalized anxiety disorder did not show an advantage over placebo for anxiety reduction. A 2024 trial at 400 mg per day reported within-group improvements, but no significant advantage over placebo on its perceived-stress scale.
For this formula: the listed 350 mg is comparable in scale to studied amounts, but that does not establish an effect from one pack or during a psychedelic session.
Magnesium and L-Theanine together
A 2022 mouse experiment found sleep-related changes with specially prepared magnesium–L-Theanine complexes. The compounds were injected and differ from taking oral magnesium glycinate and L-Theanine together.
A 2025 human trial of magnesium bisglycinate found a small improvement in insomnia severity after four weeks, without a significant improvement in perceived stress. It used 250 mg of elemental magnesium daily. That cannot be equated with the 300 mg of magnesium glycinate compound listed here.
These are useful directions for research into rest and stress physiology. They do not establish immediate calming, synergy in this formula, or protection during a psychedelic experience.
Alpha-GPC and B vitamins
Alpha-GPC supplies a choline-related cognitive rationale. A small trial in 20 resistance-trained men found improvements on the Stroop test, but not significant differences on other cognitive tests or subjective measures. Its 315 mg and 630 mg study amounts do not validate the effects of the 350 mg in this blend.
B3 participates in energy metabolism; B6 in amino-acid metabolism and neurotransmitter synthesis; B12 in normal nervous-system function. Those physiological roles do not establish an immediate benefit from extra supplementation.
Exploratory B6 mood research has used 100 mg daily for about a month, unlike the 10 mg listed here. This is not a recommendation to increase the amount. The specified 10 mg B12 also does not establish a calming or psychedelic-support effect.
Beyond completed clinical trials
The Society for In Vitro Biology’s 2024 conference report describes work on psilocybin/eugenol combinations and inflammatory pathways. It overlaps with the laboratory program above rather than providing independent human confirmation.
A GoodCap patent application proposes combining serotonergic compounds with plant compounds such as curcumin, eugenol, and piperine. A patent documents an invention and its claims; it is not clinical validation or medical approval.
A practitioner case report describes people receiving psilocybin and multi-ingredient regimens that included L-Theanine. With multiple interventions and no controlled comparison, it cannot isolate the contribution of L-Theanine, establish causation, or validate Sitter. Such reports can generate questions for better-designed studies.
What remains
to be established.
No controlled human study of this complete ten-ingredient Sitter formula with psychedelics was located in the research reviewed here. That is a limit of this targeted review, not proof that no study exists.
- Finished-formula effects: whether the ingredients produce useful benefits together at these amounts.
- Preparation and exposure: how extract content, ingredient forms, and absorption compare with the studies.
- Interactions: how the complete formula behaves alongside medicines or psychoactive substances. Piperine’s effects on drug metabolism make this a substantive question.
- Actual experience: whether any measured biological change translates to greater comfort, less anxiety, or better outcomes for people.
Emerging evidence makes these questions worth studying. It does not establish that this product treats anxiety or inflammation, prevents a difficult experience, or is safe with psilocybin, LSD, MDMA, or ketamine.
← Back to Sitter